Literature DB >> 23698547

Body mass index as a risk factor for increased serum lactate during craniotomy.

M Garavaglia1, T Mak, M D Cusimano, A Rigamonti, C Crescini, V McCredy, A Romaschin, A J Baker, G M T Hare.   

Abstract

BACKGROUND: An increase in serum lactate can occur in patients undergoing craniotomy. We hypothesized that prolonged craniotomy for brain tumor resection leads to inadequate tissue perfusion as demonstrated by increased level of lactate. This study attempts to determine the mechanism and identify any modifiable risk factors. METHODS. Prospective, observational study of 18 patients undergoing craniotomy for brain tumor resection. The primary outcome was that peak serum lactate would correlate with length of surgery. Secondary outcomes included lactate at 3, 6 and 9 hours, creatine kinase (CK) and myoglobinuria overtime. These values were correlated with expected risk factors for lactatemia including length of surgery, Body Mass Index (BMI), hypotension, hemoglobin and mannitol therapy. RESULTS. Serum lactate consistently increased in the first 3 hours in all patients (2.21±1.22 mmol/L) with a peak increase at 9 hours (3.73±1.62 mmol/L) (P<0.05 for both). The peak serum lactate did not correlate with length of surgery (P=0.799). However, the change in lactate over 3 hours (Δ3hrLactate) did correlate with BMI (P=0.010). Serum CK was increased at 12 hours (P<0.05) and reached a peak level greater than 1000 U/L in 8 of 18 patients. Six of these patients experienced myoglobinuria. No other parameters correlated with increased lactate.
CONCLUSION: We observed a consistent and early increase in serum lactate in patients undergoing craniotomy, which correlated with BMI, but not length of surgery. Associated increases in CK and myoglobinuria support the hypothesis that elevated BMI contributed to muscle ischemia and tissue breakdown during craniotomy. Future studies are required to establish the overall clinical significance and mechanism of hyperlactatemia during neurosurgery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23698547

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  4 in total

1.  Hyperlactatemia in children following brain tumor resection: prevalence, associated factors, and clinical significance.

Authors:  Miri Gelbart; Elhanan Nahum; Maoz Gelbart; Eytan Kaplan; Gili Kadmon; Amir Kershenovich; Helen Toledano; Avichai Weissbach
Journal:  Childs Nerv Syst       Date:  2021-12-02       Impact factor: 1.475

2.  Factors affecting serum lactate in patients with intracranial tumors - A report of our series and review of the literature.

Authors:  Eleonora Ioannoni; Giuseppe Grande; Alessandro Olivi; Massimo Antonelli; Anselmo Caricato; Nicola Montano
Journal:  Surg Neurol Int       Date:  2020-03-06

3.  Hyperlactatemia After Intracranial Tumor Surgery Does Not Affect 6-Month Survival: A Retrospective Case Series.

Authors:  Peter P de Smalen; Tom J van Ark; Robert J Stolker; Arnaud J P E Vincent; Markus Klimek
Journal:  J Neurosurg Anesthesiol       Date:  2020-01       Impact factor: 3.969

4.  Hyperlactatemia associated with elective tumor craniotomy: Protocol for an observational study of pathophysiology and clinical implications.

Authors:  Alexandra Vassilieva; Kirsten Møller; Jane Skjøth-Rasmussen; Martin Kryspin Sørensen
Journal:  PLoS One       Date:  2022-07-21       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.